| Literature DB >> 35237466 |
Daniel L Hall1, Gloria Y Yeh2, Conall O'Cleirigh1, Jeffrey Peppercorn1, Lynne I Wagner3, John Denninger1, Andrea J Bullock2, Helen R Mizrach1, Brett Goshe1, Tina Cheung2, Raissa Li1, Alexandros Markowitz1, Elyse R Park1.
Abstract
BACKGROUND: For cancer survivors, there is a paucity of fear of recurrence (FOR) interventions that integrate empirically supported mind-body and psychological skills for managing FOR and are delivered in scalable formats.Entities:
Keywords: cancer; fear of recurrence; intervention adaptation; mind-body; qualitative methods; survivorship
Year: 2022 PMID: 35237466 PMCID: PMC8883302 DOI: 10.1177/21649561221074690
Source DB: PubMed Journal: Glob Adv Health Med ISSN: 2164-9561
Overview of Sequential Intervention Adaptation Process.
| Step | Description | Resulting Takeaways |
|---|---|---|
|
| - Examined literature on FOR interventions | - |
| - Convened experts in (a) the SMART-3RP intervention, (b) cancer survivorship, and (c) clinician stakeholders at recruitment site | - | |
| - | ||
| - | ||
|
| - Synthesized findings from Step 1 into initial adaptation of treatment manual | - |
| - | ||
| - 23 survivors participated in the in-person intervention (4 cohorts of 3-8 survivors) | - | |
| - Assessed acceptability after each session and patient-reported outcomes at baseline, post-intervention, +1 month, and +3 months | - Preliminary acceptability: 87% of post-session ratings were “High” or “Very High” in enjoyability | |
| - Exit interviews assessed survivors’ feedback about multimodal nature of intervention | - Preliminary feasibility: 96% retention baseline to 3-month follow-up; 77% session attendance, feasibility of skills practice (16% at baseline, 76%post-intervention) | |
| - Reductions in FOR post-intervention (d = 0.87) and 3-month follow-up | ||
| - | ||
| - Eligibility: Expand to include long-term survivors and restrict to elevated FOR. | ||
| - Content: For all skill modalities, provide guidance on when to apply techniques when engaging in healthcare. | ||
|
| - 28 survivors participated in focus groups to identify FOR-related coping skills and healthcare engagement (3 focus groups w/ elevated FOR, 3 focus groups w/ non-elevated FOR) | - |
| - Survivors with elevated FOR (n = 15) were interviewed individually to identify preferences for intervention delivery | - | |
| - | - | |
| - | - | |
| - | - | |
|
| - Adapted content of existing treatment manual based on Step 4 | - |
| - Finalized treatment manual | ||
| - Planned pilot feasibility RCT (ORBIT Phase IIb: Pilot) |
Summary of Adapted Session Content.
| Smart-3RP Content | Adapted Content Targeting FOR |
|---|---|
Note: Sessions are delivered weekly and last approximately 90 minutes each.
aApplied throughout Sessions 1-8.
Characteristics of Participants in Step 3 Single Arm Pilot Study and Step 4 Stratified Focus Groups and Individual Interviews.
| Step 3 (N = 23) | Step 4 (N = 28) | |
|---|---|---|
| N (%)/Mean (Range) | ||
|
| 61.0 (35-88) | 53.1 (23-74) |
|
| 20 (86.9%) | 20 (71.4%) |
|
| ||
| Asian | 0 (0%) | 2 (7.1%) |
| African American | 2 (8.7%) | 1 (3.6%) |
| Multiracial | 1 (4.3%) | 0 (0%) |
| White | 20 (86.9%) | 24 (85.7%) |
| | 0 (0%) | 1 (3.6%) |
|
| ||
| Blood/hematologic malignancy | 1 (4.3%) | 10 (35.7%) |
| Breast | 9 (39.1%) | 9 (32.1%) |
| Colon/gastric | 9 (39.1%) | 5 (17.9%) |
| Gynecological | 3 (13.0%) | 4 (14.3%) |
| Prostate | 0 (0%) | 1 (3.6%) |
| Kidney | 0 (0%) | 1 (3.6%) |
| Lung | 2 (8.7%) | 1 (3.6%) |
| Melanoma | 1 (4.3%) | 1 (3.6%) |
| Retinoblastoma | 0 (0%) | 1 (3.6%) |
| Sinus tumor | 0 (0%) | 1 (3.6%) |
| Thyroid | 0 (0%) | 1 (3.6%) |
|
| 12.3 (3-30) | 43.7 (3-252) |
|
| ||
| Chemotherapy | 18 (78.3%) | 18 (64.3%) |
| Radioactive iodine | 8 (34.8%) | 1 (3.6%) |
| Stem cell transplant | 0 (0%) | 1 (3.6%) |
| Surgery | 22 (95.6%) | 20 (71.4%) |
aSurvivors could have received treatment for more than 1 cancer.
Figure 1.Integrated FOR treatment model adapted from the SMART-3RP model.